News Focus
News Focus
icon url

biomanbaba

10/19/13 9:49 PM

#2062 RE: umiak #2058

NAVB is the ultimate sleeper

While most are snoozing the fine people there are CRANKING OUT RECORD sales
due to their recent MEDICARE reimbursement approval. Top that off with some off label use due to physicians who understand Lymphoseek will be the new standard of care....and want it for their patients NOW rather than LATER.
Then go ahead and add the steamroller which will move on the SECOND FDA APPROVAL happening later in 2013. The shorts active now will find themselves scrambling to get covered when these factors collide.....get cheap shares now and watch the show from high dollar SEATS